Tampilkan postingan dengan label detect. Tampilkan semua postingan
Tampilkan postingan dengan label detect. Tampilkan semua postingan

Senin, 20 Juni 2011

Ovarian cancer: symptoms, risk factors and how to detect

Today I will talk about a serial killer to many women. This is one of the cancers that threaten the lives of women because it is often asymptomatic

We will discuss in brief "ovaries". The ovaries are glands present on the sides of the uterus. The ovary has two functions:

1. In order to produce hormones (estrogen and progesterone)

2. During the period of child-bearing, it releases an egg every month

After menopause, the ovaries ceases to eggs but continues to produce hormones but at a slower pace. This cancer occurs when cells in the ovary begin to multiply and grow rapidly.

In many women with ovarian cancer, there are no symptoms. And if you have symptoms, they are not specific.

Symptoms include:

-Abdominal discomfort or fulfillment
-Dyspepsia
-Pelvic pain
-Constipation
-Back pain.

Because the symptoms are not specific, typically patients have when it happened the spread. That is why it is a "silent killer".

There are risk factors for ovarian cancer, such as:

-Low parity
-Maternity leave delayed
-Diet high in fat

Genetics may play a role. A gene known as BRCA 1 gene is associated with breast - ovarian syndrome.

Our objective is to detect as soon as possible and will be doing a routine in postmenopausal women annual pelvic examination and we pagásemos. In addition a periodic ultrasound and CA-125 can be used to detect ovarian cancer

Once diagnosed, treatment options will depend on its type. There are many types of ovarian cancer and each has their treatment.


View the original article here

Minggu, 19 Juni 2011

Accurately HPV DNA testing can detect Cervical cancer

When a woman reaches the age of 40, she will be at risk of developing cervical cancer. This disease is mainly caused by the virus of human papillomavirus or HPV. It is transmitted by sexual contact. HPV doesn't start or become cancerous cells of cervix. However, this disease will generally be maintained over a long period and can lead to cervical cancer.

Recent studies have shown that HPV DNA tests are more accurate in detecting cervical cancer compared to traditional Pap smear. Looking at the statistics, a HPV DNA test was able to detect 95% of cases, while a Pap smear detects only 55%, both having tried the same participants.

However, it is necessary to point out that this particular DNA testing would still need a sample collected from the cervix. This test will not suffice as a blood test. It should be noted, because the news that you leaving concerning this particular DNA testing does not clarify the scope of this procedure.

Today, however, a procedure of HPV DNA is being conducted along with the traditional Pap smear. But it is also worth mentioning that a procedure of HPV DNA test costs more than traditional Pap smear - almost $90, compared with $20. One more thing, even women who have received the HPV vaccines yet are recommended for screening as there are currently more than a strain that cause cancer that is covered not yet vaccinated against HPV.

In relation to cervical cancer, early detection remains the best defence against the disease. That is why women are recommended to undergo tests which could rule out the chance of having cervical cancer. Pap smear is probably the most common test to detect cervical cancer and as mentioned above, is the most affordable test. It is by collecting cells from the cervix for examination under a microscope.

An HPV test involves testing and writing. An HPV DNA test is able to detect the presence of the most common types of HPV high risk.

In conclusion, cervical cancer, as well as any other type of cancer, early detection and treatment, have greater chance of an individual to get rid of the disease forever.

Looking for more information on HPV DNA testing? Visit http://www.dnatesting.cc/ today!


View the original article here

How to detect and prevent Cervical cancer

Thanks to the widespread screening, the incidence of cervical cancer has declined significantly. Precancerous lesions can be detected and eliminated before the become malignant. In 2010, approximately 12,200 patients are estimated to be diagnosed with cervical cancer in the United States. An estimated 4,210 will die from this disease.

Screening tests include conventional Pap smear or PAP liquid, with or without evidence of DNA for HPV (human papilloma virus). The current recommendations of the American College of Obstetricians and Gynecologists for women in normal risk are as follows:

1) Pap smear to start at age 21
(2)< 30="" years="" of="" age:="" every="" 2="" years="">
(3) > 30 years of age: every 3 years
(4) Stop the slide show at the age of 65-70, after 3 normal tests during the past 10 years.

Screening is more common for women at high risk. Conditions of high risk include previous cervical cancer, exposure to DES (diethylstilbestrol) as a fetus and conditions immunosuppressed (by Transplant organ, chemotherapy, steroids, or HIV drugs). Please note that the previous screening recommendations apply to patients "asymptomatic". If you believe that you have new symptoms, such as pelvic pain, abnormal bleeding, unusual heavy download, during urination, etc., talk to your doctor.

With the recent development of vaccine, cervical cancer is now also a potentially preventable disease. The American Cancer Society recommends HPV vaccination for girls from 11 up to 18 years. It is not clear yet if the vaccination for the 19-26 age range is beneficial or not. The vaccine Gardasil prevents four strains of HPV infection. Strains 16 and 18 cause 70% of cervical cancers and strains 6 and 11 cause 90% of genital warts cases. The Cervarix vaccine protects against strains of the HPV 16 and 18. Neither vaccine offers prevention absolute of all types of HPV in cervical cancer. Therefore women vaccinated still need to see your provider of health care of routine cervical cancer. It should be noted that recently the FDA also approved the use of the HPV vaccine for boys and men ages 9-26 for the prevention of genital warts.

Dr. Mai Brooks is a surgeon oncologist surgical/general, with experience in the early detection and prevention of cancer. More information on http://www.drbrooksmd.com/ and http://progressreportoncancer.wordpress.com/.


View the original article here